Companies / Navidea Biopharmaceuticals, Inc.
Navidea Biopharmaceuticals, Inc.
NAVBCIK 810509
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jun 29, 2023 | Scott John K Jr. Director | Grant Grant or award | Common Stock | $1.07M | +12.2M +62.39% | 31,755,832 | low |
| Mar 29, 2021 | Witter Malcolm G Director | Buy Open-market buy | Common Stock | $44.5K | +22K +84.31% | 47,000 | low |
| Mar 3, 2021 | Witter Malcolm G Director | Buy Open-market buy | Common Stock | $34.6K | +15K +142.86% | 25,500 | low |
| Sep 17, 2021 | Witter Malcolm G Director | Buy Open-market buy | Common Stock | $32.0K | +20K +25.56% | 98,257 | low |
| Jul 26, 2021 | Witter Malcolm G Director | Buy Open-market buy | Common Stock | $25.5K | +15K +23.71% | 78,257 | low |
| Apr 23, 2021 | Witter Malcolm G Director | Buy Open-market buy | Common Stock | $16.0K | +10K +21.28% | 57,000 | low |
| Feb 5, 2015 | Ford Brendan a Director | Grant Grant or award | Common Stock | $15.0K | +8K +4.39% | 188,633 | low |
| Feb 5, 2015 | Drake Peter F Director | Grant Grant or award | Common Stock | $14.4K | +8K +10.83% | 77,829 | low |